top of page
Connecting Dots
Asha Therapeutics logo-01-2 copy_edited.

Designing novel therapeutics by looking through a PRISM™

A Revolutionary Approach to Novel Drug Design

The PRISM™ platform employes a novel set of proprietary algorithms and advanced simulation programs to determine targetability and disease relevance, de novo compound design, chemistry optimization, and predict drug-like properties... all before a single synthetic reaction takes place.

De novo Chemistry and Specific Compound Design No Therapeutics Barriers, Disruptive Potential

image.png

No Compound Screening Translates to
an Accelerated Approach to Drug Discovery

image.png

The PRISM™ Advantage

image.png
image.png
image.png
image.png
image.png

Custom designed target specific compounds

ADME & PK optimized for translation to clinic

Ensured synthetic feasibility for CMC readiness

Unparelled speed to development candidate

Robust cost effectivness & reduced risk 

Connecting Dots
asha color.png
  • LinkedIn
  • Twitter

© Copyright 2023 Asha Therapeutics, all rights reserved 

Privacy Policy | Terms of Use

Website designed & maintained by A3 Media

bottom of page